Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

NCT00071422 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: INGAP-Peptide
DRUG: INGAP-Peptide
DRUG: placebo

Sponsor

Exsulin Corporation